Create
Log in
Sign up
Golden has been acquired by ComplyAdvantage.
Read about it here ⟶
US Patent 11458110 Treatment of Fragile X Syndrome with cannabidiol
Overview
Structured Data
Issues
Contributors
Activity
Access by API
Access by API
Is a
Patent
Current Assignee
Zynerba Pharmaceuticals
Date Filed
August 6, 2020
Date of Patent
October 4, 2022
Patent Applicant
Zynerba Pharmaceuticals
Patent Application Number
16986622
Patent Citations
US Patent 10568848 Treatment of autism with cannabidiol
US Patent 10213390 Treatment of fragile X syndrome with cannabidiol
US Patent 10314792 Treatment of autism with cannabidiol
US Patent 10471022 Treatment of fragile X syndrome with cannabidiol
US Patent 10555928 Cannabis extracts and methods of preparing and using same
US Patent 10758497 Treatment of fragile x syndrome with cannabidiol
Patent Jurisdiction
United States Patent and Trademark Office
Patent Number
11458110
Patent Primary Examiner
Michael V Meller
Find more entities like US Patent 11458110 Treatment of Fragile X Syndrome with cannabidiol
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Company
Home
Press & Media
Blog
Careers
WE'RE HIRING
Products
Knowledge Graph
Query Tool
Data Requests
Knowledge Storage
API
Pricing
Enterprise
ChatGPT Plugin
Legal
Terms of Service
Enterprise Terms of Service
Privacy Policy
Help
Help center
API Documentation
Contact Us
SUBSCRIBE